You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage II adult soft tissue sarcoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States (drug,

Completed
Has Results
  • Adult Angiosarcoma
  • +3 more
  • pazopanib hydrochloride
  • +4 more
  • Chicago, Illinois
  • +4 more
Jul 26, 2022

Pleomorphic Rhabdomyosarcoma, Stage IIB Adult Soft Tissue Sarcoma AJCC v7, Stage III Adult Soft Tissue Sarcoma AJCC v7 Trial in

Completed
Has Results
  • Pleomorphic Rhabdomyosarcoma
  • +3 more
  • Epirubicin Hydrochloride
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Feb 23, 2022

Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States

Completed
Has Results
  • Adult Angiosarcoma
  • +3 more
  • Santa Monica, California
  • +6 more
Mar 29, 2022

Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

Completed
Has Results
  • Adult Alveolar Soft Part Sarcoma
  • +18 more
  • Portland, Oregon
  • +1 more
Sep 23, 2021

Metastatic Malignant Tumor in the Lung, Stage IIIB NSCLC, Stage IV Adult Soft Tissue Sarcoma Trial in Buffalo (Cisplatin,

Completed
  • Metastatic Malignant Neoplasm in the Lung
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Soft Tissue Sarcoma Adult Trial (Surufatinib)

Not yet recruiting
  • Soft Tissue Sarcoma Adult
  • (no location specified)
Oct 29, 2023

Metastatic Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma Trial in Hannover (Durvalumab and Tremelimumab,

Completed
  • Metastatic Adult Soft Tissue Sarcoma
  • Recurrent Adult Soft Tissue Sarcoma
  • Hannover, Germany
    Medizinische Hochschule Hannover
Jan 18, 2023

Resectable Soft Tissue Sarcoma, Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IA Soft Tissue Sarcoma

Recruiting
  • Resectable Soft Tissue Sarcoma
  • +4 more
  • Hypofractionated Radiation Therapy
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Resectable Soft Tissue Sarcoma, Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IA Soft Tissue Sarcoma

Active, not recruiting
  • Resectable Soft Tissue Sarcoma
  • +7 more
  • Hypofractionated Radiation Therapy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 22, 2022

Stage II Adult Soft Tissue Sarcoma, Stage IIA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma Trial (drug, other,

Withdrawn
  • Stage II Adult Soft Tissue Sarcoma
  • +5 more
  • Fluorothymidine F-18
  • +2 more
  • (no location specified)
Jun 4, 2020

High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Surufatinib, Sintilimab, Radiotherapy)

Recruiting
  • High-Risk Localized Soft Tissue Sarcoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 20, 2023

Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage III Soft Tissue Sarcoma of the Trunk and Extremities

Recruiting
  • Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
  • +3 more
  • Chest Radiography
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 28, 2022

Soft Tissue Sarcoma, Sts, Sarcoma,Soft Tissue Trial in Saint Louis (ADI PEG20, Ifosfamide, Radiotherapy)

Not yet recruiting
  • Soft Tissue Sarcoma
  • +2 more
  • ADI PEG20
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 2, 2023

Soft Tissue Sarcoma Trial (Cadonilimab)

Not yet recruiting
  • Soft Tissue Sarcoma
  • Cadonilimab
  • (no location specified)
Dec 9, 2022

High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Pegylated Liposomal Doxorubicin, Doxorubicin, Anti-PD-1 mAb)

Recruiting
  • High-Risk Localized Soft Tissue Sarcoma
  • Pegylated Liposomal Doxorubicin
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2023

Neoadjuvant, Immunotherapy, Sarcoma,Soft Tissue Trial in Warsaw (Pembrolizumab, Eftilagimod alpha)

Recruiting
  • Neoadjuvant
  • +3 more
  • Pembrolizumab, Eftilagimod alpha
  • Warsaw, Poland
    Maria Sklodowska-Curie National Research Institute of Oncology
Nov 7, 2023

Sarcoma,Soft Tissue, Brachytherapy, Poly(ADP-ribose) Polymerase Inhibitors Trial in Guangzhou (Fluzoparib, Radioactive particle

Recruiting
  • Sarcoma,Soft Tissue
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 30, 2023

Leiomyosarcoma, Liposarcoma, Soft Tissue Sarcoma Adult Trial in Taipei (Eribulin, Lenvatinib)

Active, not recruiting
  • Leiomyosarcoma
  • +3 more
  • Taipei, Taiwan
  • +1 more
Dec 27, 2022

Soft Tissue Sarcoma Trial in Guangzhou (Chiauranib)

Recruiting
  • Soft Tissue Sarcoma
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Univerisity
Sep 14, 2022

Soft Tissue Sarcoma, Adult Soft Tissue Sarcoma, Resectable Soft Tissue Sarcoma Trial in Lyon (radiation, other, procedure)

Not yet recruiting
  • Soft Tissue Sarcoma
  • +2 more
  • Neoadjuvant RT
  • +3 more
  • Lyon, Rhône, France
    Centre Léon Bérard
Jan 12, 2023

Soft Tissue Sarcoma Trial in Washington (hypofractionation)

Not yet recruiting
  • Soft Tissue Sarcoma
  • hypofractionation
  • Washington, District of Columbia
    Sibley Memorial Hospital
Jun 14, 2023

Advanced Soft-tissue Sarcoma Trial (LB-100 plus Doxorrubicin, Doxorubicin)

Not yet recruiting
  • Advanced Soft-tissue Sarcoma
  • (no location specified)
Apr 11, 2023

Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,

Recruiting
  • Leiomyosarcoma
  • +29 more
  • Definitive Surgical Resection
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Apr 26, 2022

Efficacy and Safety of Surufatinib Combined With Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma

Not yet recruiting
  • Efficacy and Safety of Surufatinib Combined With Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients
  • Surufatinib + envafolimab
  • (no location specified)
Feb 1, 2023

Soft Tissue Sarcoma Adult, Angiosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in Denmark, Norway, Sweden (Propranolol,

Recruiting
  • Soft Tissue Sarcoma Adult
  • +2 more
  • Aarhus, Denmark
  • +3 more
Jul 23, 2023